Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 1 115 IDR 0.9%
Market Cap: 52.3T IDR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+18%
Revenue
Forecast
+8%
Operating Income
Forecast
+13%
Net Income
Forecast
+16%

Wall Street
Price Targets

KLBF Price Targets Summary
Kalbe Farma Tbk PT

Wall Street analysts forecast KLBF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KLBF is 1 732.15 IDR with a low forecast of 1 414 IDR and a high forecast of 2 310 IDR.

KLBF Lowest Forecast
Wall Street Target
1 414 IDR
27% Upside
KLBF Average Forecast
Wall Street Target
1 732.15 IDR
55% Upside
KLBF Highest Forecast
Wall Street Target
2 310 IDR
107% Upside
Lowest
Price Target
1 414 IDR
27% Upside
Average
Price Target
1 732.15 IDR
55% Upside
Highest
Price Target
2 310 IDR
107% Upside
Kalbe Farma Tbk PT Competitors:
Price Targets
AUROPHARMA
Aurobindo Pharma Ltd
25% Upside
ALM
Almirall SA
26% Upside
4547
Kissei Pharmaceutical Co Ltd
3% Upside
P
PLTH
Planet 13 Holdings Inc
223% Upside
AUROPHARMA
Aurobindo Pharma Ltd
25% Upside
ALM
Almirall SA
26% Upside
4547
Kissei Pharmaceutical Co Ltd
3% Upside
P
PLTH
Planet 13 Holdings Inc
223% Upside
O
ORNBV
Orion Oyj
2% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
1% Downside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Kalbe Farma Tbk PT

For the last 8 years the compound annual growth rate for Kalbe Farma Tbk PT's revenue is 7%. The projected CAGR for the next 3 years is 8%.

7%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Kalbe Farma Tbk PT

For the last 8 years the compound annual growth rate for Kalbe Farma Tbk PT's operating income is 4%. The projected CAGR for the next 3 years is 11%.

4%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Kalbe Farma Tbk PT

For the last 8 years the compound annual growth rate for Kalbe Farma Tbk PT's net income is 4%. The projected CAGR for the next 3 years is 12%.

4%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
KLBF intrinsic value, competitors valuation, and company profile.
DCF Valuation
KLBF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KLBF stock valuation using valuation multiples.
Wall Street Estimates
KLBF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KLBF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KLBF's stock price target?
Price Target
1 732.15 IDR

According to Wall Street analysts, the average 1-year price target for KLBF is 1 732.15 IDR with a low forecast of 1 414 IDR and a high forecast of 2 310 IDR.

What is Kalbe Farma Tbk PT's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Kalbe Farma Tbk PT's revenue is 7%. The projected CAGR for the next 3 years is 8%.

What is Kalbe Farma Tbk PT's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Kalbe Farma Tbk PT's operating income is 4%. The projected CAGR for the next 3 years is 11%.

What is Kalbe Farma Tbk PT's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Kalbe Farma Tbk PT's net income is 4%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.